{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["19"],"submitter":["Madero-Velazquez L"],"funding":["Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa","Takeda","abbvie","pfizer","Lilly","biogen","galápagos"],"pubmed_abstract":["<h4>Background</h4>Hidradenitis suppurativa (HS) is a chronic, recurrent skin disease that may be associated with inflammatory bowel disease (IBD).<h4>Objectives</h4>This study aimed to describe the features and therapeutic requirements of IBD and HS in patients who present both entities and the risk factors for HS development in patients with IBD.<h4>Methods</h4>Case-controlled, retrospective study of all patients diagnosed with IBD-HS in the ENEIDA registry. Cases were paired 1:2 with controls (IBD without HS).<h4>Design</h4>This was a retrospective, case-control study.<h4>Results</h4>A total of 819 patients were included: 273 patients with IBD-HS and 546 controls. Female sex (62% vs 44%, <i>p</i> = 0.0001), active smoking (45% vs 18%, <i>p</i> = 0.0001), Crohn's disease (CD; 83% vs 55%,"],"journal":["Therapeutic advances in gastroenterology"],"pagination":["17562848261423351"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12924924"],"repository":["biostudies-literature"],"pubmed_title":["Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry."],"pmcid":["PMC12924924"],"pubmed_authors":["Yague C","Riestra S","Ruiz-Nunez I","Huguet J","Bujanda L","Elorza A","Calvet X","Ricart-Gomez E","Molina M","Manosa M","Martin-Arranz MD","Domenech E","Soto P","Gargallo-Pueyo C","Martinez-Montiel P","Gonzalez-Vivo M","Herreros B","Aguas M","Igualada L","Zabana Y","Pascual JC","Sierra-Ausin M","Monfort D","Arguelles F","Rodriguez-Moranta F","Zabalza-San Martin L","Madero-Velazquez L","Camba AH","Roig C","Mesonero F","Marin-Jimenez I","Belen-Galipienso O","Alba C","Gutierrez A","Catala L","Zapater P","Lorente R","Garcia MJ","Busquets D","Barreiro-de Acosta M","Ramirez de la Piscina P","Botella B","Ramos L","Ponferrada A","de Francisco R","Gisbert JP"],"additional_accession":[]},"is_claimable":false,"name":"Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA Registry.","description":"<h4>Background</h4>Hidradenitis suppurativa (HS) is a chronic, recurrent skin disease that may be associated with inflammatory bowel disease (IBD).<h4>Objectives</h4>This study aimed to describe the features and therapeutic requirements of IBD and HS in patients who present both entities and the risk factors for HS development in patients with IBD.<h4>Methods</h4>Case-controlled, retrospective study of all patients diagnosed with IBD-HS in the ENEIDA registry. Cases were paired 1:2 with controls (IBD without HS).<h4>Design</h4>This was a retrospective, case-control study.<h4>Results</h4>A total of 819 patients were included: 273 patients with IBD-HS and 546 controls. Female sex (62% vs 44%, <i>p</i> = 0.0001), active smoking (45% vs 18%, <i>p</i> = 0.0001), Crohn's disease (CD; 83% vs 55%,","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026","modification":"2026-07-16T18:48:41.615Z","creation":"2026-07-12T03:08:44.674Z"},"accession":"S-EPMC12924924","cross_references":{"pubmed":["41732327"],"doi":["10.1177/17562848261423351"]}}